← 전체 보충제 목록

NALT

N-Acetyl L-Tyrosine (NALT)

📑 PubMed 17편 🧬 아미노산

📚 관련 논문 (17편)

1.
Co-localization of porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus in nasopharynx-associated lymphoid tissue in pigs with PCV2 subclinical infection.
Journal of comparative pathology 2026 PMID:42019463

1. J Comp Pathol. 2026 Apr 21;227:24-30. doi: 10.1016/j.jcpa.2026.04.003. Online ahead of print. Co-localization of porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus in nasopharynx-associated lymphoid tissue in pigs with PCV2 subclinical infection. Yamashi

2.
Nasal germinal centers and IgA class-switch recombination depend on CCR6 and B cell receptor affinity.
The Journal of experimental medicine 2026 PMID:41665602

2. J Exp Med. 2026 Apr 6;223(4):e20251901. doi: 10.1084/jem.20251901. Epub 2026 Feb 10. Nasal germinal centers and IgA class-switch recombination depend on CCR6 and B cell receptor affinity. Liu J(1), Stoler-Barak L(1), Shulman Z(1). Author information: (1)Department of Systems Immunology, Weiz

3.
Development of a chitosan-based acid-responsive mucoadhesive mRNA vaccine for eliciting mucosal and systemic immunity.
Carbohydrate polymers 2026 PMID:41617284

3. Carbohydr Polym. 2026 Apr 1;377:124871. doi: 10.1016/j.carbpol.2025.124871. Epub 2026 Jan 4. Development of a chitosan-based acid-responsive mucoadhesive mRNA vaccine for eliciting mucosal and systemic immunity. Zhou Y(1), Jiang Y(2), Wu Y(2), Hong S(2), Ding F(2), Cai H(3). Author informati

4.
Analysis of the Short- and Long-Term Immune Response in BALB/c Mice Immunized with Total Naegleria fowleri Extract Co-Administered with Cholera Toxin.
Tropical medicine and infectious disease 2026 PMID:41591231

4. Trop Med Infect Dis. 2026 Jan 12;11(1):22. doi: 10.3390/tropicalmed11010022. Analysis of the Short- and Long-Term Immune Response in BALB/c Mice Immunized with Total Naegleria fowleri Extract Co-Administered with Cholera Toxin. Gutiérrez-Sánchez M(1), Ortega-Juárez ML(1), Carrasco-Yépez MM(2),

5.
Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.
Frontiers in immunology 2025 PMID:41403947

5. Front Immunol. 2025 Dec 1;16:1691163. doi: 10.3389/fimmu.2025.1691163. eCollection 2025. Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway. Mian MF(1)(2), Ghasemi R(1)(2), Bagri P(1)(2), McGrath JJC(1)(2),

6.
Relationship Between Group 3 Innate Lymphoid Cells and Th17 in Human Nasopharynx-Associated Lymphoid Tissue and the Association With Pneumococcal Carriage.
The Journal of infectious diseases 2025 PMID:41104672

6. J Infect Dis. 2025 Dec 20;232(6):e972-e980. doi: 10.1093/infdis/jiaf488. Relationship Between Group 3 Innate Lymphoid Cells and Th17 in Human Nasopharynx-Associated Lymphoid Tissue and the Association With Pneumococcal Carriage. Zaki L(1), Xu R(1), Sharma R(2), Krishnan M(2), Leong S(3), Derb

7.
[Transferon Oral(®) reduces IgE levels and cellular infiltration in NALT in a murine model of allergic rhinitis].
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2025 PMID:41037701

7. Rev Alerg Mex. 2025 Sep 30;72(3):76. doi: 10.29262/ram.v72i3.1512. [Transferon Oral(®) reduces IgE levels and cellular infiltration in NALT in a murine model of allergic rhinitis]. [Article in Spanish; Abstract available in Spanish from the publisher] Trejo-Martínez I(1)(2)(3), Fragozo A(1)(2

8.
Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.
Antiviral research 2025 PMID:41015121

8. Antiviral Res. 2025 Nov;243:106284. doi: 10.1016/j.antiviral.2025.106284. Epub 2025 Sep 25. Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses. Zhang W(1), Prévost J(2), Sloan A(2), Tamming L(1), Pfeifle A(1), Gravel C(3),

9.
Treatment of bacterial biothreat agents with a novel purified bioactive lactoferrin affects both growth and biofilm formation.
Frontiers in cellular and infection microbiology 2025 PMID:40599649

9. Front Cell Infect Microbiol. 2025 Jun 17;15:1603689. doi: 10.3389/fcimb.2025.1603689. eCollection 2025. Treatment of bacterial biothreat agents with a novel purified bioactive lactoferrin affects both growth and biofilm formation. Xander C(#)(1), Martinez EE(#)(1), Toothman RG(1), Gardner CL(

10.
Murine nasal-associated lymphoid tissue (NALT) harbors human alphaherpesvirus 1 (HSV-1) DNA during latency, and dexamethasone triggers viral replication.
Journal of virology 2025 PMID:40135894

10. J Virol. 2025 Apr 15;99(4):e0225124. doi: 10.1128/jvi.02251-24. Epub 2025 Mar 26. Murine nasal-associated lymphoid tissue (NALT) harbors human alphaherpesvirus 1 (HSV-1) DNA during latency, and dexamethasone triggers viral replication. Harrison KS(1), Cowan SR(1), Jones C(1). Author informa

11.
Distribution of CD4+, CD8 + and CD20 + intraepithelial cells in normal nasal mucosa and sinonasal polyps: a preliminary, observational study.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2026 PMID:41786943

11. Eur Arch Otorhinolaryngol. 2026 Mar 5. doi: 10.1007/s00405-026-10086-2. Online ahead of print. Distribution of CD4+, CD8 + and CD20 + intraepithelial cells in normal nasal mucosa and sinonasal polyps: a preliminary, observational study. Thandayuthapani V(1), Jacob J(1), Gowri M(2), Rabi S(1)

12.
Targeting aerosol delivery to regions of nasal-associated lymphoid tissue (NALT) in three dimensional models of human intranasal airways using the BiVax intranasal atomizer.
Frontiers in drug delivery 2024 PMID:40836969

12. Front Drug Deliv. 2024 Nov 11;4:1456538. doi: 10.3389/fddev.2024.1456538. eCollection 2024. Targeting aerosol delivery to regions of nasal-associated lymphoid tissue (NALT) in three dimensional models of human intranasal airways using the BiVax intranasal atomizer. Laube BL(1), Kesavan J(2)

13.
Mucosal Vaccination Against SARS-CoV-2 Using Human Probiotic Bacillus subtilis Spores as an Adjuvant Induces Potent Systemic and Mucosal Immunity.
Vaccines 2025 PMID:40733749

13. Vaccines (Basel). 2025 Jul 21;13(7):772. doi: 10.3390/vaccines13070772. Mucosal Vaccination Against SARS-CoV-2 Using Human Probiotic Bacillus subtilis Spores as an Adjuvant Induces Potent Systemic and Mucosal Immunity. Ramos Pupo R(1)(2)(3), Reyes Diaz LM(1), Suarez Formigo GM(4)(5)(6), Borre

14.
Mucosal immunity in upper and lower respiratory tract to MERS-CoV.
Frontiers in immunology 2024 PMID:39281686

14. Front Immunol. 2024 Aug 30;15:1358885. doi: 10.3389/fimmu.2024.1358885. eCollection 2024. Mucosal immunity in upper and lower respiratory tract to MERS-CoV. Shrwani KJ(1)(2), Mahallawi WH(3), Mohana AI(4), Algaissi A(5)(6), Dhayhi N(7), Sharwani NJ(8), Gadour E(9)(10), Aldossari SM(11), Asir

15.
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas.
BMJ open 2024 PMID:39019638

15. BMJ Open. 2024 Jul 17;14(7):e083277. doi: 10.1136/bmjopen-2023-083277. Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas. McGovern DP(1)(2), McClure ME(3)(2), Coates M(3)(2), Bond S(4), M

16.
A rat model of adenoid hypertrophy constructed by using ovalbumin and lipopolysaccharides to induce allergy, chronic inflammation, and chronic intermittent hypoxia.
Animal models and experimental medicine 2025 PMID:38572767

37. Animal Model Exp Med. 2025 Feb;8(2):353-362. doi: 10.1002/ame2.12396. Epub 2024 Apr 4. A rat model of adenoid hypertrophy constructed by using ovalbumin and lipopolysaccharides to induce allergy, chronic inflammation, and chronic intermittent hypoxia. Liu A(1), Zhang Y(2), Lin Y(1), Li X(1)

17.
Altered intestinal microbiota enhances adenoid hypertrophy by disrupting the immune balance.
Frontiers in immunology 2023 PMID:38090578

44. Front Immunol. 2023 Nov 28;14:1277351. doi: 10.3389/fimmu.2023.1277351. eCollection 2023. Altered intestinal microbiota enhances adenoid hypertrophy by disrupting the immune balance. Liu W(1)(2), Jiang H(1)(2), Liu X(3), Zheng Y(1)(2), Liu Y(1)(2), Pan F(1)(2), Yu F(1)(2), Li Z(4), Gu M(5),

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.